A Study on Medical Management in End Stage Renal Disease In Patient on Haemodialysis
Journal Title: IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) - Year 2018, Vol 13, Issue 4
Abstract
End –stage renal disease (ESRD) is the final stage of chronic kidney disease in which the kidney no longer function well enough to meet the needs of dailylife. Based on this, a Prospective Observational study was performedin Department of Medicine, at RMMCH, Annamalai University, TamilNadu, period of study 6 months; Between November 2016 and April 2017. Totally 54 patients were enrolled based on the inclusion and exclusion criteria.The patients were counseled about their disease and lifestyle modification. The objective of the study is to find out the socio-demographic characteristics of ESRD patients, to observe the variation in blood pressure before and after hemodialysis, anemic condition in hemodialysis patient and to study the drug use pattern in ESRD patients at RMMCH. In our study we observed that males are majorly affected with ESRD and the patients of age group of 30-40 years are mostly affected than other age group.The working status of the patients enrolled in our study was mostly daily wagers and farmers. In male the risk factor of alcohol consumption is mostly noticed. By observing both pre and post dialysis data we could be noticed that there is an increase in blood pressure after dialysis, but in few patients we also observed that decrease in BP after dialysis. In our study the mean of the haemoglobin level is low as compared with the target range recommended by the KDOQI guidelines and they are treated with injection iron sucrose and erythropoietin to increase the Hgb level. Blood transfusions are given only to the patients with very poor haemoglobin level. Among all the antihypertensive drugs prescribed amlodipine (calcium channel blocker) was majorly prescribed drug, followed by (cardioselective beta blocker). Combination of diuretic and calcium channel blockers was commonly prescribed in DM with HT patients. From our study we conclude that monotherapy is preferred for the haemodialysis patients on long term use of antihypertensive drugs for the better control of blood pressure.
Authors and Affiliations
Likitha Nanga, Geena Gimson, G. Veeramani, ,Dr . K. Baburaj
Keywords
Related Articles
- EP ID EP395494
- DOI 10.9790/3008-1304021116
- Views 105
- Downloads 0
Biological investigations of different leaf extracts of Litsea liyuyingi (Family-Lauraceae)
In this present study, the leaf extracts of Litsea liyuyingi, were subjected to evaluate the phytochemical screenings, thrombolytic, membrane stabilizing, antioxidant, antimicrobial, cytotoxic, antinociceptive, anti-diar...
Association between Elevated Serum Ferritin and HBA1C in Type 2 Diabetes Mellitus
Background and objectives : Diabetes is a disease of metabolic dysregulation. Recent studies have emphasized the role of serum ferritin in insulin resistance and the incidence of diabetes mellitus. However, the role of f...
Mini Review: Antitumor promotion as the best strategy for chemoprevention
Transformation of normal cell to cancer cell is known to be a multiple step process known as carcinogenesis. A lot of chemopreventive agents have been isolated from plant derived phytocompound reported to exhibit potent...
Effect of Dietary Counseling on Protein Energy Wasting in Hemodialysis Patients
Protein Energy Wasting (PEW) is a state of decreased body stores of protein energy in the most advanced stages of chronic kidney disease maintaining hemodialysis. The main objective of this study is to assess the PEW in...
Circulating Resistin Concentrations, Inflammatory Biomarkers and Insulin Resistance in Iraqi Patients with Chronic Kidney Failure
Background: Resistin in humans is mainly produced by blood-derived leukocytes and mononuclear cells. Resistin antagonizes the effects of insulin on glucose metabolism in liver and skeletal muscle, interacts with and rein...